We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Calcium Supplements Useless in Averting Hip Fracture

By HospiMedica staff writers
Posted on 24 Dec 2007
A new study has found that calcium from food as well as from supplements does not prevent hip fractures in men and women, and that supplements may even increase the fracture risk.

Researchers at the University Hospital Zurich (Switzerland) conducted a meta-analysis in which they combined results from 12 double blind, randomized, placebo-controlled trials, as well as observational cohort studies of calcium intake and hip fractures. More...
The meta-analysis included seven prospective cohort studies of 170,991 women with 2,954 hip fractures and five that included 68,606 men with 214 hip fractures. Studies in which calcium supplements were combined with other nutrients, such as vitamin D, were excluded.

The researchers found that among women, there was no association between total calcium intake and hip fracture risk. Among men, the pooled risk ratio per 300 mg of total calcium a day was 0.92. On the basis of five clinical trials (including 5,666 women, primarily postmenopausal, and 1,074 men) with 814 nonvertebral fractures, the pooled relative risk for nonvertebral fractures between calcium supplementation (800-1600 mg/d) and placebo was 0.92. On the other hand, they found that in four clinical trials with separate results for hip fracture (6,504 individuals with 139 fractures), the pooled relative risk showed a 64% increased hip fracture risk between calcium (800 and 1200 mg/d) and placebo. The study was published in the December 2007 issue of the American Journal of Clinical Nutrition.

"This meta-analysis highlights the importance of not segmenting nutrition into heterogeneous populations and isolated nutrients. Bone is not just calcium, and calcium does not function in isolation,” concluded lead author Heike A. Bischoff-Ferrari, M.D., and colleagues.

The researchers explained that calcium supplementation or the consumption of calcium-rich foods is commonly recommended for the prevention of osteoporosis and fractures, based on controlled trials with bone density as the outcome. However, normal serum levels of 25-hydroxyvitamin D are necessary for optimal calcium absorption from the gastrointestinal tract.


Related Links:
University Hospital Zurich

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.